WASHINGTON — Merck CEO Robert Davis and Johnson & Johnson CEO Joaquin Duato have agreed to voluntarily testify earlier than the Senate well being committee, avoiding a threatened subpoena, the committee introduced Friday.
The choice by the executives got here after a public strain marketing campaign by Sanders to get the 2 executives and Bristol Myers Squibb CEO Chris Boerner to testify about why costs for his or her medication are larger in the US than in different international locations. Sanders had scheduled a vote to subpoena the Merck and Johnson & Johnson CEOs on Jan. 31, however canceled it on Friday.
“Using a subpoena was clearly a final resort and I’m delighted that these CEOs might be coming into our committee voluntarily,” Sanders stated in a written assertion.
